Expression and function of syndecan-4 in human platelets

Thrombosis and Haemostasis

Volumn 93, Issue 6, 2005, Pages 1120-1127

  Kaneider, Nicole C ^a   Feistritzer, Clemens ^a   Gritti, Donatella ^b   Mosheimer, Birgit A ^a   Ricevuti, Giovanni ^b   Patsch, Josef R ^a   Wiedermann, Christian J ^a,c  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF PAVIA   (Italy)

^c CENTRAL HOSPITAL OF BOLZANO   (Italy)

Author keywords

Antithrombin; Cell cell interactions; Disseminated intravascular coagulation (DIC) sepsis; Heparins glycosaminoglycans; Platelet pharmacology

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTITHROMBIN; CD40 LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN ANTIBODY; SYNDECAN 4;

ARTICLE; DISSEMINATED INTRAVASCULAR CLOTTING; FLUORESCENCE ACTIVATED CELL SORTING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; WESTERN BLOTTING;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTITHROMBINS; BLOOD PLATELETS; CD40 LIGAND; GENE EXPRESSION; HUMANS; INFLAMMATION MEDIATORS; MEMBRANE GLYCOPROTEINS; NEUTROPHILS; PLATELET ACTIVATION; PROTEOGLYCANS; RESPIRATORY BURST; RNA, MESSENGER; SIGNAL TRANSDUCTION; SYNDECAN-4;

EID: 20444436791     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-11-0763     Document Type: Article

References (32)

1. Neame PB, Kelton JG, Walker IR et al. Thrombocytopenia in septicemia: the role of disseminated intravascular coagulation. Blood 1980; 56: 88-92.
2. Warkentin TE, Aird WC, Rand JH. Platelet-endothelial interactions: Sepsis, HIT, and antiphospholipid syndrome. hematology (Am Soc Hematol Educ Program). 2003: 497-519.
3. Dahlback B. Blood coagulation. Lancet 2000; 355: 1627-32.
4. Gailani D, Ho D, Sun MF et al. Model for a factor IX activation complex on blood platelets: dimeric conformation of factor XIa is essential. Blood 2001; 97: 3117-22.
5. Monkovic DD, Tracy PB. Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin. J Biol Chem 1990; 265: 17132-40.
6. Hechler B, Leon C, Vial C et al. The P2Y1 receptor is necessary for adenosine 5′-diphosphate-induced platelet aggregation. Blood 1998; 92: 152-9.
7. Daniel JL, Dangelmaier C, Jin J et al. Role of intracellular signaling events in ADP-induced platelet aggregation. Thromb Haemost 1999; 82: 1322-6.
8. Bengtsson T, Zalavary S, Stendahl O et al. Release of oxygen metabolites from chemoattractant-stimulated neutrophils is inhibited by resting platelets: role of extracellular adenosine and actin polymerization. Blood 1996; 87: 4411-23.
9. Kaul S, Waack BJ, Padgett RC et al. Interaction of human platelets and leukocytes in modulation of vascular tone. Am J Physiol 1994; 266: H1706-1714.
10. Kaneider NC, Egger P, Dunzendorfer S et al. Rho-GTPase-dependent platelet-neutrophil interaction affected by HMG-CoA reductase inhibition with altered adenosine nucleotide release and function. Arterioscler Thromb Vasc Biol 2002; 22: 1029-35.
11. Warren BL, Eid A, Singer P et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001; 286: 1869-78.
12. Hoffmann JN, Vollmar B, Laschke MW et al. Adverse effect of heparin on antithrombin action during endotoxemia: microhemodynamic and cellular mechanisms. Thromb Haemost 2002; 88: 242-52.
13. Kaneider NC, Egger P, Dunzendorfer S et al. Syndecan-4 as antithrombin receptor of human neutrophils. Biochem Biophys Res Commun 2001; 287: 42-6.
14. Kaneider NC, Forster E, Mosheimer B et al. Syndecan-4-dependent signaling in the inhibition of endotoxin-induced endothelial adherence of neutrophils by antithrombin. Thromb Haemost 2003; 90: 1150-7.
15. Kaneider NC, Reinisch CM, Dunzendorfer S et al. Syndecan-4 mediates antithrombin-induced chemotaxis of human peripheral blood lymphocytes and monocytes. J Cell Sci 2002; 115: 227-36.
16. Fitzgerald ML, Wang Z, Park PW et al. Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J Cell Biol 2000; 148: 811-24.
17. Damus PS, Rosenberg RD. Antithrombin-heparin cofactor. Methods Enzymol 1976; 45: 653-69.
18. Wiedermann CJ, Niedermuhlbichler M, Braunsteiner H, Widermann CJ. Priming of polymorphonuclear neutrophils by atrial natriuretic peptide in vitro. J Clin Invest 1992; 89: 1580-6.
19. Kaneider NC, Egger P, Dunzendorfer S et al. Reversal of thrombin-induced deactivation of CD39/ATP-Dase in endothelial cells by HMG-CoA reductase inhibition: effects on Rho-GTPase and adenosine nucleotide metabolism. Arterioscler Thromb Vasc Biol 2002; 22: 894-900.
20. Kindness G, Williamson FB, Long WF. Inhibition by antithrombin III of carrageenan- and xylan SP54-induced aggregation of human blood platelets [proceedings]. Biochem Soc Trans 1980; 8: 84-5.
21. Carrell RW. How serpins are shaping up. Science 1999; 285: 1861.
22. Di Virgilio F, Solini A. P2 receptors: new potential players in atherosclerosis. Br J Pharmacol 2002; 135: 831-42.
23. Schiffrin EL. The endothelium and control of blood vessel function in health and disease. Clin Invest Med 1994; 17: 602-20.
24. Chung AW, Jurasz P, Hollenberg MD et al. Mechanisms of action of proteinase-activated receptor agonists on human platelets. Br J Pharmacol 2002; 135: 1123-32.
25. Bernfield M, Gotte M, Park PW et al. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999; 68: 729-77.
26. Lee JC, Laydon JT, McDonnell PC et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994; 372: 739-46.
27. Dangelmaier C, Jin J, Daniel JL et al. The P2Y1 receptor mediates ADP-induced p38 kinase-activating factor generation in human platelets. Eur J Biochem 2000; 267: 2283-9.
28. May AE, Kalsch T, Massberg S et al. Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells. Circulation 2002; 106: 2111-7.
29. Inwald DP, McDowall A, Peters MJ et al. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 2003; 92: 1041-8.
30. Esmon CT. The regulation of natural anticoagulant pathways. Science 1987; 235: 1348-52.
31. Dunzendorfer S, Kaneider N, Rabensteiner A et al. Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III. Blood 2001; 97: 1079-85.
32. Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999; 341: 586-92.